CJC and Ipamorelin: How This Growth Hormone Peptide Stack Works

CJC-1295 and ipamorelin are two synthetic peptides that are frequently combined to stimulate growth hormone (GH) release from the pituitary gland. CJC-1295 acts as a growth hormone-releasing hormone (GHRH) analog, while ipamorelin binds the ghrelin receptor to trigger a GH pulse. Both are sold as research chemicals, and neither is FDA-approved for human use in the United States.

What Are CJC-1295 and Ipamorelin?

CJC-1295 is a modified form of GHRH engineered to resist enzymatic breakdown in the body. It comes in two versions: CJC-1295 with DAC (drug affinity complex), which binds to albumin and stays active for days, and CJC-1295 without DAC, better known as MOD GRF(1-29) or mod grf 1-29, which clears within roughly 30 minutes.

Ipamorelin is a pentapeptide that mimics ghrelin, the hormone that signals the pituitary to release GH. It is often described as the most selective ghrelin mimetic because it triggers very little cortisol or prolactin release compared with older peptides in the same class.

How the two peptides compare

Peptide	Also known as	Mechanism	Approximate half-life	Common research dose
CJC-1295 with DAC	DAC:GRF	GHRH receptor agonist	6-8 days	1-2 mg per week
CJC-1295 without DAC	MOD GRF(1-29), mod grf 1-29	GHRH receptor agonist	~30 minutes	100-200 mcg per dose
Ipamorelin	N/A	Ghrelin / GHS-R agonist	~2 hours	100-300 mcg per dose

Why People Stack CJC-1295 With Ipamorelin

Growth hormone release is controlled by two separate signals: GHRH and ghrelin. Hitting both pathways at once produces a larger, more physiological GH pulse than either peptide can create alone.

That is the entire logic behind the cjc ipamorelin stack. Because the two compounds act on different receptors, they amplify each other instead of competing for the same binding site.

• CJC-1295 helps set the amplitude of the GH pulse.
• Ipamorelin triggers the release and tends to cause fewer hunger and cortisol effects than GHRP-2 or GHRP-6.
• Together they are usually described as producing a cleaner pulse than older ghrelin mimetics.

This is also why a cjc ipamorelin blend is often sold as a single vial with both peptides in a fixed ratio. People asking about cjc no dac ipamorelin are generally looking for the short-acting version, since the DAC-free form is cleared quickly and dosed more often.

Typical CJC-1295 and Ipamorelin Dosage

There is no FDA-approved human dosage for CJC-1295 and ipamorelin. Every number circulating online comes from forum logs, vendor guides, or laboratory protocols rather than prescribing guidelines.

That said, the most commonly cited research-style approach pairs a GHRH analog with ipamorelin two to three times per day, with the final dose taken before sleep.

Protocol style	Typical dose	Frequency	Timing notes
CJC-1295 with DAC + ipamorelin	1-2 mg CJC weekly, 100-300 mcg ipamorelin	Ipamorelin 2-3x daily	CJC dosed weekly; ipamorelin before bed
CJC-1295 without DAC + ipamorelin	100-200 mcg each	2-3x daily	Fasted, last dose before sleep
Fixed blend vial	200-300 mcg total per injection	2-3x daily	Fasted, consistent schedule

Because growth hormone is released naturally during deep sleep, most users inject the ipamorelin cjc combination before bed on an empty stomach. Injecting close to a meal blunts the GH response, since rising insulin and glucose both suppress it.

What Results Do People Report?

Anyone searching for cjc-1295 ipamorelin results before and after will find anecdotal logs rather than controlled trials. Reported changes tend to be gradual and subtle, which is very different from anabolic steroids.

Timeframe	Effects users most often describe
Weeks 1-2	Deeper sleep, vivid dreams, falling asleep faster
Weeks 3-6	Improved recovery between workouts, less joint stiffness, better mood
Weeks 8-12	Modest changes in body composition, improved skin and hair quality
Beyond 12 weeks	Diminishing returns, and no long-term safety data

Threads on cjc-1295 and ipamorelin reddit tend to emphasize sleep quality, joint comfort, and recovery time far more than dramatic muscle gain. A meaningful share of users also report no noticeable change at all.

Side Effects and Safety

Commonly reported cjc and ipamorelin side effects include injection-site redness, water retention, tingling or numbness in the hands, increased appetite, and mild lethargy right after dosing. Most of these are described as temporary and dose-dependent.

If you are asking what are the side effects of cjc 1295 and ipamorelin, the bigger concern is what is not known. No long-term human safety studies exist, and unregulated peptides may contain impurities or be mislabeled.

• Compounds that raise growth hormone can also raise blood glucose and may worsen insulin resistance.
• People with active cancer, uncontrolled diabetes, or pituitary disease are generally advised to avoid GH-stimulating peptides.
• Anyone considering this stack should discuss it with a licensed healthcare professional first.

Some users pair this stack with cjc 1295 ipamorelin and bpc-157 for connective tissue recovery, but that three-peptide combination has never been evaluated in controlled human trials.

Legal Status and Sourcing

CJC-1295 and ipamorelin are not approved by the FDA for human use. In the United States they are sold as research chemicals, which means purity, dosing accuracy, and sterility vary widely between vendors.

Forum reviews and vendor comparison threads are everywhere, but third-party certificates of analysis are the only meaningful quality signal. Even then, a certificate reflects only the sample that was tested, not the entire batch.

Bottom Line

CJC-1295 and ipamorelin are a popular pairing because they stimulate growth hormone through two complementary pathways. The evidence for meaningful body composition change in humans is thin, and the long-term safety data is essentially absent.

Treat this stack as an experimental research compound, verify sourcing carefully, and speak with a healthcare professional rather than relying on forum anecdotes alone.

COMMON QUESTIONS

Frequently Asked Questions

Can you take CJC-1295 and ipamorelin together?

Yes, many people combine them, and the two peptides are often drawn into the same syringe and injected together. Because CJC-1295 acts on the GHRH receptor and ipamorelin acts on the ghrelin receptor, they are complementary rather than redundant. Neither peptide is FDA-approved for human use, so any combination use is unregulated and off-label.

What is CJC-1295 without DAC?

CJC-1295 without DAC is also called MOD GRF(1-29) or mod grf 1-29, and it is a short-acting GHRH analog with a half-life of roughly 30 minutes. It is usually paired with ipamorelin and dosed two to three times daily on an empty stomach. CJC-1295 with DAC is the longer-acting version that stays active for several days after a single injection.

How long does CJC-1295 and ipamorelin take to work?

Most user logs describe improved sleep and recovery within the first two to four weeks of consistent use. Changes in body composition, if they occur at all, are typically reported after eight to twelve weeks. No controlled human trials confirm these timelines, so they should be treated as anecdotal.